Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 364

1.

Comparison of Clinical Outcomes of One and Two-level Total Disc Replacement: 4-year Results from a Prospective, Randomized, Controlled, Multicenter IDE Clinical Trial.

Bae HW, Kim KD, Nunley PD, Jackson RJ, Hisey MS, Davis RJ, Hoffman GA, Gaede SE, Danielson GO 3rd, Peterson DL, Stokes JM, Araghi A.

Spine (Phila Pa 1976). 2015 Mar 17. [Epub ahead of print]

PMID:
25785955
2.

Public awareness of and support for infrastructure changes designed to increase walking and biking in Los Angeles County.

Gase LN, Barragan NC, Simon PA, Jackson RJ, Kuo T.

Prev Med. 2015 Mar;72:70-5. doi: 10.1016/j.ypmed.2014.12.033. Epub 2015 Jan 5.

PMID:
25572622
3.

IL-17A Expression in HIV-Specific CD8 T Cells Is Regulated by IL-4/IL-13 Following HIV-1 Prime-Boost Immunization.

Ravichandran J, Jackson RJ, Trivedi S, Ranasinghe C.

J Interferon Cytokine Res. 2015 Mar;35(3):176-85. doi: 10.1089/jir.2014.0078. Epub 2014 Dec 10.

PMID:
25493691
4.

Two-level total disc replacement with Mobi-C cervical artificial disc versus anterior discectomy and fusion: a prospective, randomized, controlled multicenter clinical trial with 4-year follow-up results.

Davis RJ, Nunley PD, Kim KD, Hisey MS, Jackson RJ, Bae HW, Hoffman GA, Gaede SE, Danielson GO 3rd, Gordon C, Stone MB.

J Neurosurg Spine. 2015 Jan;22(1):15-25. doi: 10.3171/2014.7.SPINE13953.

PMID:
25380538
5.

Different HIV pox viral vector-based vaccines and adjuvants can induce unique antigen presenting cells that modulate CD8 T cell avidity.

Trivedi S, Jackson RJ, Ranasinghe C.

Virology. 2014 Nov;468-470:479-89. doi: 10.1016/j.virol.2014.09.004. Epub 2014 Sep 28.

6.

Use of an in vivo FTA assay to assess the magnitude, functional avidity and epitope variant cross-reactivity of T cell responses following HIV-1 recombinant poxvirus vaccination.

Wijesundara DK, Ranasinghe C, Jackson RJ, Lidbury BA, Parish CR, Quah BJ.

PLoS One. 2014 Aug 29;9(8):e105366. doi: 10.1371/journal.pone.0105366. eCollection 2014.

7.

IL-4 and IL-13 receptors: Roles in immunity and powerful vaccine adjuvants.

Ranasinghe C, Trivedi S, Wijesundara DK, Jackson RJ.

Cytokine Growth Factor Rev. 2014 Aug;25(4):437-42. doi: 10.1016/j.cytogfr.2014.07.010. Epub 2014 Jul 23.

PMID:
25159217
8.

Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.

Jackson RJ, Worley M, Trivedi S, Ranasinghe C.

Vaccine. 2014 Sep 29;32(43):5703-14. doi: 10.1016/j.vaccine.2014.08.023. Epub 2014 Aug 20.

9.

The organization of RNA contacts by PTB for regulation of FAS splicing.

Mickleburgh I, Kafasla P, Cherny D, Llorian M, Curry S, Jackson RJ, Smith CW.

Nucleic Acids Res. 2014 Jul;42(13):8605-20. doi: 10.1093/nar/gku519. Epub 2014 Jun 23.

10.

Progresses in DNA-based heterologous prime-boost immunization strategies.

Jackson RJ, Boyle DB, Ranasinghe C.

Methods Mol Biol. 2014;1143:61-90. doi: 10.1007/978-1-4939-0410-5_5.

PMID:
24715282
11.

Persistent gastrocutaneous fistula: factors affecting the need for closure.

Wyrick DL, Bozeman AP, Smith SD, Jackson RJ, Maxson RT, Kelley KR, Mathews DL, Li J, Swearingen CJ, Dassinger MS.

J Pediatr Surg. 2013 Dec;48(12):2506-10. doi: 10.1016/j.jpedsurg.2013.06.001.

PMID:
24314194
12.

Fem1b promotes ubiquitylation and suppresses transcriptional activity of Gli1.

Gilder AS, Chen YB, Jackson RJ 3rd, Jiang J, Maher JF.

Biochem Biophys Res Commun. 2013 Oct 25;440(3):431-6. doi: 10.1016/j.bbrc.2013.09.090. Epub 2013 Sep 25.

PMID:
24076122
13.

IL-4 and IL-13 mediated down-regulation of CD8 expression levels can dampen anti-viral CD8⁺ T cell avidity following HIV-1 recombinant pox viral vaccination.

Wijesundara DK, Jackson RJ, Tscharke DC, Ranasinghe C.

Vaccine. 2013 Sep 23;31(41):4548-55. doi: 10.1016/j.vaccine.2013.07.062. Epub 2013 Aug 6.

PMID:
23933364
14.

Health and the built environment: 10 years after.

Jackson RJ, Dannenberg AL, Frumkin H.

Am J Public Health. 2013 Sep;103(9):1542-4. doi: 10.2105/AJPH.2013.301482. Epub 2013 Jul 18. No abstract available.

PMID:
23865699
15.

Unique IL-13Rα2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8(+) T-cell avidity and protective immunity.

Ranasinghe C, Trivedi S, Stambas J, Jackson RJ.

Mucosal Immunol. 2013 Nov;6(6):1068-80. doi: 10.1038/mi.2013.1. Epub 2013 Feb 13.

PMID:
23403475
16.

Reduced interleukin-4 receptor α expression on CD8+ T cells correlates with higher quality anti-viral immunity.

Wijesundara DK, Tscharke DC, Jackson RJ, Ranasinghe C.

PLoS One. 2013;8(1):e55788. doi: 10.1371/journal.pone.0055788. Epub 2013 Jan 31.

17.

The current status of vertebrate cellular mRNA IRESs.

Jackson RJ.

Cold Spring Harb Perspect Biol. 2013 Feb 1;5(2). pii: a011569. doi: 10.1101/cshperspect.a011569. Review.

18.

Defining the roles and interactions of PTB.

Kafasla P, Mickleburgh I, Llorian M, Coelho M, Gooding C, Cherny D, Joshi A, Kotik-Kogan O, Curry S, Eperon IC, Jackson RJ, Smith CW.

Biochem Soc Trans. 2012 Aug;40(4):815-20. doi: 10.1042/BST20120044. Review.

PMID:
22817740
19.

Mobility and aging: new directions for public health action.

Satariano WA, Guralnik JM, Jackson RJ, Marottoli RA, Phelan EA, Prohaska TR.

Am J Public Health. 2012 Aug;102(8):1508-15. doi: 10.2105/AJPH.2011.300631. Epub 2012 Jun 14. Review.

20.

Role of novel type I interferon epsilon in viral infection and mucosal immunity.

Xi Y, Day SL, Jackson RJ, Ranasinghe C.

Mucosal Immunol. 2012 Nov;5(6):610-22. doi: 10.1038/mi.2012.35. Epub 2012 May 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk